McKesson to acquire controlling stake in Core Ventures for $2.49 billion in cash
McKesson said it hopes to “bring advanced treatments and improved care experiences to patients, while also reducing the overall cost of care.”
McKesson said it hopes to “bring advanced treatments and improved care experiences to patients, while also reducing the overall cost of care.”
